Guangdong Marubi Biotechnology Co (603983) - Total Liabilities
Based on the latest financial reports, Guangdong Marubi Biotechnology Co (603983) has total liabilities worth CN¥1.46 Billion CNY (≈ $212.96 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Guangdong Marubi Biotechnology Co (603983) cash flow conversion to assess how effectively this company generates cash.
Guangdong Marubi Biotechnology Co - Total Liabilities Trend (2011–2024)
This chart illustrates how Guangdong Marubi Biotechnology Co's total liabilities have evolved over time, based on quarterly financial data. Check Guangdong Marubi Biotechnology Co asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Guangdong Marubi Biotechnology Co Competitors by Total Liabilities
The table below lists competitors of Guangdong Marubi Biotechnology Co ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Korean Reinsu
KO:003690
|
Korea | ₩9.69 Trillion |
|
Meridianlink Inc
NYSE:MLNK
|
USA | $544.29 Million |
|
Aerosun Corp
SHG:600501
|
China | CN¥2.90 Billion |
|
Scientex Bhd
KLSE:4731
|
Malaysia | RM3.30 Billion |
|
Métropole Télévision S.A.
PA:MMT
|
France | €641.20 Million |
|
Guangdong Guanghua Sci-Tech Co Ltd
SHE:002741
|
China | CN¥1.71 Billion |
|
Leggett & Platt Incorporated
NYSE:LEG
|
USA | $2.51 Billion |
|
Hengbao Co Ltd
SHE:002104
|
China | CN¥247.11 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down Guangdong Marubi Biotechnology Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Guangdong Marubi Biotechnology Co market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.81 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guangdong Marubi Biotechnology Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guangdong Marubi Biotechnology Co (2011–2024)
The table below shows the annual total liabilities of Guangdong Marubi Biotechnology Co from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.62 Billion ≈ $236.48 Million |
+56.11% |
| 2023-12-31 | CN¥1.04 Billion ≈ $151.48 Million |
+23.44% |
| 2022-12-31 | CN¥838.64 Million ≈ $122.72 Million |
+39.04% |
| 2021-12-31 | CN¥603.19 Million ≈ $88.26 Million |
-24.07% |
| 2020-12-31 | CN¥794.44 Million ≈ $116.25 Million |
+3.66% |
| 2019-12-31 | CN¥766.40 Million ≈ $112.15 Million |
+4.27% |
| 2018-12-31 | CN¥735.02 Million ≈ $107.56 Million |
+14.31% |
| 2017-12-31 | CN¥643.00 Million ≈ $94.09 Million |
-0.74% |
| 2016-12-31 | CN¥647.79 Million ≈ $94.79 Million |
-0.32% |
| 2015-12-31 | CN¥649.88 Million ≈ $95.10 Million |
+8.77% |
| 2014-12-31 | CN¥597.49 Million ≈ $87.43 Million |
+22.90% |
| 2013-12-31 | CN¥486.14 Million ≈ $71.14 Million |
+3.47% |
| 2012-12-31 | CN¥469.82 Million ≈ $68.75 Million |
+4.65% |
| 2011-12-31 | CN¥448.94 Million ≈ $65.69 Million |
-- |
About Guangdong Marubi Biotechnology Co
Guangdong Marubi Biotechnology Co., Ltd. engages in the research and development, design, production, sale, and service of various cosmetics in China. The company provides skin care, make up, and eye care products. It offers its products under the Marubi, Lianhuo, Haruji, and the Love Fire brand names. The company was founded in 2002 and is based in Guangzhou, China.